REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,873,224 | -45.7% | 424,867 | +19.8% | 0.00% | -100.0% |
| Q2 2023 | $8,975,888 | -33.4% | 354,638 | -15.2% | 0.00% | -33.3% |
| Q1 2023 | $13,472,315 | -24.9% | 418,265 | -56.9% | 0.00% | -25.0% |
| Q4 2022 | $17,934,222 | +25.0% | 971,518 | +82.8% | 0.00% | 0.0% |
| Q3 2022 | $14,353,000 | +208.9% | 531,581 | +58.1% | 0.00% | – |
| Q2 2022 | $4,646,000 | -54.6% | 336,244 | -35.9% | 0.00% | -100.0% |
| Q1 2022 | $10,226,000 | +54.4% | 524,437 | +29.2% | 0.00% | – |
| Q4 2021 | $6,622,000 | +18.3% | 405,806 | +101.9% | 0.00% | – |
| Q3 2021 | $5,599,000 | +4.5% | 200,988 | +11.2% | 0.00% | – |
| Q2 2021 | $5,359,000 | -28.5% | 180,807 | -32.5% | 0.00% | -100.0% |
| Q1 2021 | $7,490,000 | -44.3% | 267,968 | -43.6% | 0.00% | 0.0% |
| Q4 2020 | $13,454,000 | +137.8% | 474,726 | +111.0% | 0.00% | 0.0% |
| Q3 2020 | $5,657,000 | +34.9% | 225,027 | +31.1% | 0.00% | 0.0% |
| Q2 2020 | $4,193,000 | +71.7% | 171,684 | +4.1% | 0.00% | 0.0% |
| Q1 2020 | $2,442,000 | -21.7% | 164,981 | -14.1% | 0.00% | – |
| Q4 2019 | $3,119,000 | +23.8% | 192,132 | -0.9% | 0.00% | – |
| Q3 2019 | $2,520,000 | -55.9% | 193,796 | -56.0% | 0.00% | – |
| Q2 2019 | $5,712,000 | +425.0% | 440,273 | +538.1% | 0.00% | – |
| Q1 2019 | $1,088,000 | +251.0% | 69,000 | +348.1% | 0.00% | – |
| Q4 2018 | $310,000 | -84.8% | 15,400 | -81.3% | 0.00% | – |
| Q3 2018 | $2,044,000 | -8.2% | 82,258 | +1.4% | 0.00% | – |
| Q2 2018 | $2,226,000 | -18.2% | 81,100 | -8.2% | 0.00% | -100.0% |
| Q1 2018 | $2,720,000 | -76.1% | 88,300 | -72.2% | 0.00% | -75.0% |
| Q4 2017 | $11,369,000 | +285.0% | 318,005 | +196.8% | 0.00% | +300.0% |
| Q3 2017 | $2,953,000 | +143.8% | 107,162 | +133.5% | 0.00% | – |
| Q2 2017 | $1,211,000 | +64.1% | 45,900 | +29.3% | 0.00% | – |
| Q1 2017 | $738,000 | +12.5% | 35,500 | +11.9% | 0.00% | – |
| Q4 2016 | $656,000 | +285.9% | 31,714 | +202.0% | 0.00% | – |
| Q3 2016 | $170,000 | -60.6% | 10,500 | -66.9% | 0.00% | – |
| Q2 2016 | $431,000 | -75.1% | 31,700 | -68.0% | 0.00% | – |
| Q1 2016 | $1,729,000 | -75.2% | 98,981 | -51.4% | 0.00% | -100.0% |
| Q4 2015 | $6,959,000 | +129.3% | 203,713 | +99.7% | 0.00% | – |
| Q3 2015 | $3,035,000 | +153.1% | 101,989 | +172.1% | 0.00% | – |
| Q2 2015 | $1,199,000 | +33.8% | 37,484 | -13.2% | 0.00% | – |
| Q1 2015 | $896,000 | +155.3% | 43,200 | +318.2% | 0.00% | – |
| Q2 2014 | $351,000 | – | 10,331 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |